FDA advisory committee

FDA conference hall

Biotech

FDA to end 9-month adcomm hiatus with review of AZ cancer drugs

The April 30 event is also the first ODAC meeting after longtime FDA oncology czar Richard Pazdur, M.D., suddenly retired in December.

Angus Liu Mar 6, 2026 11:16am

Duchenne muscular dystrophy DMD

Capricor shares turn red as FDA announces deramiocel adcomm plan

May 6, 2025 8:32am

FDA Adcomm

After agony, FDA adcomm favors Stealth's ultra-rare disease drug

Oct 10, 2024 6:20pm

FDA

FDA scraps adcomm for Applied's rare disease drug

Sep 18, 2024 8:00am

speak chat talk world spread debate globe Earth

With MDMA debate spreading, Lykos CEO tries to dispel concerns

Jun 13, 2024 10:22am

brain alzheimers dementia neuroscience gears thought think

Lilly's donanemab sails through FDA meeting with 2 yes votes

Jun 10, 2024 5:11pm